Subscribe to RSS
DOI: 10.1055/s-0030-1259007
Mild and General One-Pot Reduction and Cyclization of Aromatic and Heteroaromatic 2-Nitroamines to Bicyclic 2H-Imidazoles
Publication History
Publication Date:
14 October 2010 (online)

Abstract
A one-pot procedure for the conversion of aromatic and heteroaromatic 2-nitroamines into bicyclic 2H-benzimidazoles is described. The procedure employs formic acid, iron powder, and an additive such as NH4Cl to reduce the nitro group and effect the imidazole cyclization with high-yielding conversions generally within one to two hours. The compatibility with a wide range of functionality demonstrates the general utility of this procedure.
Key words
cyclization - heterocycles - imidazole - iron - reduction
- 1a
Horton DA.Bourne GT.Smythe ML. Chem. Rev. 2003, 103: 893Reference Ris Wihthout Link - 1b
Spasov AA.Yozhitsa IN.Bugaeva LI.Anisimova VA. Pharm. Chem. J. 1999, 33: 232Reference Ris Wihthout Link - 2
Ding S.Gray NS.Ding Q.Schultz PG. Tetrahedron Lett. 2001, 42: 8751 - 3a
Phillips MA. J. Chem. Soc. 1928, 2393Reference Ris Wihthout Link - 3b
Wright JB. Chem. Rev. 1951, 48: 397Reference Ris Wihthout Link - 3c
Subasinghe NL.Travins JM.Ali F.Huang H.Ballentine SK.Marugan JJ.Khalil E.Hufnagel HR.Bone RF.Desjarlais RL.Crysler CS.Ninan N.Cummings MD.Molloy CJ.Tomczuk BE. Bioorg. Med. Chem. Lett. 2006, 16: 2200Reference Ris Wihthout Link - 3d
Minetti P.Tinti MO.Carminati P.Castorina M.Di Cesare MA.Serio SD.Gallo G.Ghirardi O.Giorgi F.Giorgi L.Piersanti G.Bartoccini F.Tarzia G. J. Med. Chem. 2005, 48: 6887Reference Ris Wihthout Link - 3e
Suzuki N.Tanaka Y.Dohmori R. Chem. Pharm. Bull. 1980, 28: 235Reference Ris Wihthout Link - 3f
Seley KL.O’Daniel PI.Salim S. Nucleosides, Nucleotides Nucleic Acids 2003, 22: 2133Reference Ris Wihthout Link - 3g
Maron D.Kontorowitsch M.Bloch J.-J. Ber. Dtsch. Chem. Ges. 1914, 47: 1352Reference Ris Wihthout Link - 3h
van Galen PJM.Nissen P.van Wijngaarden I.Ijzerman AP.Soudijn W. J. Med. Chem. 1991, 34: 1202Reference Ris Wihthout Link - 3i
Palmer BD.Smaill JB.Boyd M.Boschelli DH.Doherty AM.Hamby JM.Khatana SS.Kramer JB.Kraker AJ.Panek RL.Lu GH.Dahring TK.Winters RT.Showalter HDH.Denny WA. J. Med. Chem. 1998, 41: 5457Reference Ris Wihthout Link - 4a
Boydston AJ.Pecinovsky CS.Chao ST.Bielawski CW. J. Am. Chem. Soc. 2007, 129: 14550Reference Ris Wihthout Link - 4b
Wallace EM,Lyssikatos JP,Marlow AL, andHurley TB. inventors; US 2003/216460 A1.Reference Ris Wihthout Link - 4c
Huisgen R. Justus Liebigs Ann. Chem. 1948, 559: 101Reference Ris Wihthout Link - 4d
Cholody WM.Hernandez L.Hassner L.Scudiero DA.Djurickovic DB.Michejda CJ. J. Med. Chem. 1995, 38: 3043Reference Ris Wihthout Link - 4e
VanVliet DS.Gillespie P.Scicinski JJ. Tetrahedron Lett. 2005, 46: 6741Reference Ris Wihthout Link - 4f
Chen JJ.Thakur KD.Clark MP.Laughlin SK.George KM.Bookland RG.Davis JR.Cabrera EJ.Easwaran V.De B.Zhang YG. Bioorg. Med. Chem. Lett. 2006, 16: 5633Reference Ris Wihthout Link - 4g
Boydston AJ.Khramov DM.Bielawski CW. Tetrahedron Lett. 2006, 47: 5123Reference Ris Wihthout Link - 4h
Boydston AJ.Vu PD.Dykhno OL.Chang V.Wyatt AR.Stockett AS.Ritschdorff ET.Shear JB.Bielawski CW. J. Am. Chem. Soc. 2008, 130: 3143Reference Ris Wihthout Link - 5a
Roth T.Morningstar ML.Boyer PL.Hughes SH.Buckheit RW.Michejda CJ. J. Med Chem. 1997, 40: 4199Reference Ris Wihthout Link - 5b
Nozary H.Piguet C.Tissot P.Bernardinelli G.Bunzli J.-CG.Deschenaux R.Guillon D. J. Am. Chem. Soc. 1998, 120: 12274Reference Ris Wihthout Link - 5c
Suami T.Day A. J. Org. Chem. 1959, 24: 1340Reference Ris Wihthout Link - 5d
Piguet C.Bocquet B. Helv. Chim. Acta 1994, 77: 931Reference Ris Wihthout Link - 5e
McKenzie BM.Miller AK.Wojtecki RJ.Johnson JC.Burke KA.Tzeng KA.Mather PT.Rowan SJ. Tetrahedron 2008, 64: 8488Reference Ris Wihthout Link - 6a
Radl S.Hradil P. Coll. Czech. Chem. Commun. 1991, 56: 2420Reference Ris Wihthout Link - 6b
Efremov IV,Rogers BN,Duplantier AJ,Zhang L,Zhang Q, andMaklad NS. inventors; US 2008/0312271 A1.Reference Ris Wihthout Link - 7a
Wu W.-L.Burnett DA.Spring R.Greenlee WJ.Smith M.Favreau L.Fawzi A.Zhang H.Lachowicz JE. J. Med. Chem. 2005, 48: 680Reference Ris Wihthout Link - 7b
Burnett DA, andWu W.-L. inventors; US 2008/312218 A1.Reference Ris Wihthout Link - 7c
Bounaud P.-Y,Smith CR, andJefferson EA. inventors; WO 2008/51808 A2.Reference Ris Wihthout Link - 7d
Foster R.Ing HR.Rogers EF. J. Chem. Soc. 1957, 1671Reference Ris Wihthout Link - 7e
Bolger J,Castelhano AL,Crew AP,Dong H.-Q,Honda A,Laufer R,Li A.-H,Mulvihill K,Qui L,Sambrook-Smith CP,Sun Y,Wynne GM, andZhang T. inventors; WO 2005/21531A1.Reference Ris Wihthout Link - 7f
Crew AP,Cox M,Laufer R,Pegg NA,Smith S,Peter C,Sun Y,Wilkes RD, andWilliams J. inventors; US 2006/116402 A1.Reference Ris Wihthout Link -
Bongartz J.-P,Andre M,Meerpoel L,Boeckx GM,Van Lommen G,Buyck C,Obrecht D,Ermert P, andLuther A. inventors; WO 2008/148840 A1. (a)Reference Ris Wihthout Link - (b)
Popil’nichenko SV.Brovarets BS.Drach BS. Russ. J. Org. Chem. 2004, 40: 219Reference Ris Wihthout Link - 11a FeCl2 has
been reported to reductively cleave isoxazoles:
Auricchio S.Bini A.Pastormerlo E.Truscello AM. Tetrahedron 1997, 53: 10911Reference Ris Wihthout Link - 11b Nitro-isoxazoles have been
reported to undergo acid-catalyzed thermal isomerization and hydrolysis:
Pinho e Melo TMVD. Curr. Org. Chem. 2005, 9: 925Reference Ris Wihthout Link - 12a
Krasovskiy A.Malakhov V.Gavryushin A.Knochel P. Angew. Chem. Int. Ed. 2006, 45: 6040Reference Ris Wihthout Link - 12b
Krasovskiy A.Knochel P. Angew. Chem. Int. Ed. 2004, 43: 3333Reference Ris Wihthout Link - 12c
Wunderlich SH.Knochel P. Angew. Chem. Int. Ed. 2009, 48: 9717Reference Ris Wihthout Link - 13
Piller FM.Appukkuttan P.Gavryushin A.Helm M.Knochel P. Angew. Chem. Int. Ed. 2008, 47: 6802 - 14
Wundt E. Ber. Dtsch. Chem. Ges. 1878, 11: 826 - 15
v. Auwers K.Maws W. Ber. Dtsch. Chem. Ges. 1928, 61: 2415 - 16
Fischer O.Rigaud M. Ber. Dtsch. Chem. Ges. 1901, 34: 4204 - 17
Sekikawa I. Bull. Chem. Soc. Jpn. 1958, 31: 252 - 18
Van Vliet DS.Gillespie P.Scicinski JJ. Tetrahedron Lett. 2005, 46: 6741 - 19
Fischer O. Ber. Dtsch. Chem. Ges. 1904, 37: 557 - 20
Rabiger DJ.Joullie MM. J. Chem. Soc. 1964, 915 - 21
Rabiger DJ.Joullie MM. J. Org. Chem. 1961, 26: 1649 - 22
Howell JR.Rasmussen M. Austr. J. Chem. 1993, 46: 1177 - 23
Robinson FM.Miller IM.McPherson JF.Folkers K. J. Am. Chem. Soc. 1955, 77: 5192 - 24
Weidenhagen R.Weeden U. Ber. Dtsch. Chem. Ges. 1938, 71: 2347 - 25
Graboyes H.Day AR. J. Am. Chem. Soc. 1957, 79: 6421 - 26
Rousseau RJ.Robins RK. J. Heterocycl. Chem. 1965, 2: 196
References and Notes
The role of the alcohol co-solvent in this reaction is to increase solubilization of the substrate and may be omitted for substrates with good solubility in neat formic acid (unpublished observation).
9If the reaction is followed by LC-MS at shorter time intervals, the progression from starting material to bisaniline to N-formylated aniline to cyclized product can typically be observed.
10
Analytical Data
for Compounds 2-19
1-Ethyl-1
H
-benzo[
d
]imidazole
¹6
(2)
ESI-MS: m/z = 147.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 8.23
(s, 1 H), 7.62 (dd, J = 18.0,
7.9 Hz, 2 H), 7.22 (dt, J = 15.0,
7.2 Hz, 2 H), 4.28 (q, J = 7.3
Hz, 2 H), 1.41 (t, J = 7.3
Hz, 3 H).
1-Phenyl-1
H
-benzo[
d
]imidazole
¹7
(3)
ESI-MS: m/z = 195.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 8.56
(s, 1 H), 7.78 (dd, J = 6.5,
2.3 Hz, 1 H), 7.69 (dd, J = 8.4,
1.1 Hz, 2 H), 7.67-7.60 (m, 3 H), 7.51 (t, J = 7.2 Hz,
1 H), 7.38-7.28 (m, 2 H).
N
,
N
-Dimethyl-1
H
-benzo[
d
]imidazol-6-amine (4)
ESI-MS: m/z = 162.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.0
(br s, 1 H), 7.96 (s, 1 H), 7.40 (br s, 1 H), 6.78 (d, J = 7.9 Hz,
2 H), 2.88 (s, 6 H).
5-Ethoxy-1
H
-benzo[
d
]imidazole
¹8
(5)
ESI-MS: m/z = 163.0 [M + H]+. ¹H
NMR (400 MHz, DMSO, reported as a mixture of tautomers): δ = 12.25
(br s, 0.4 H), 12.20 (br s, 0.6 H), 8.10 (br s, 0.4 H), 8.04 (br
s, 0.6 H), 7.49 (br d, J = 8.8
Hz, 0.6 H), 7.38 (br d, J = 8.2
Hz, 0.4 H), 7.14 (br s, 0.4 H), 6.98 (br s, 0.6 H), 6.83-6.77
(m, 1 H), 4.03 (q, J = 6.9
Hz, 2 H), 1.34 (t, J = 6.9
Hz, 3 H).
1
H
-Benzo[
d
]imidazole-5-carbonitrile
¹9
(6)
ESI-MS: m/z = 144.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.96
(s, 1 H), 8.47 (s, 1 H), 8.16 (s, 1 H), 7.76 (d, J = 8.0
Hz, 1 H), 7.59 (d, J = 8.1
Hz, 1 H).
5-Chloro-1
H
-benzo[
d
]imidazole
²0
(7)
ESI-MS: m/z = 152.9 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.60
(s, 1 H), 8.27 (s, 1 H), 7.62 (m, 2 H), 7.22 (d, J = 7.7
Hz, 1 H).
4-Chloro-1
H
-benzo[
d
]imidazole
²¹
(8)
ESI-MS: m/z = 153.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 8.31
(s, 1 H), 7.55 (d, J = 7.9
Hz, 1 H), 7.30-7.05 (m, 2 H).
5-Iodo-1
H
-benzo[
d
]imidazole
²²
(9)
ESI-MS: m/z = 244.9 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.52
(br s, 1 H), 8.19 (s, 1 H), 7.95 (s, 1 H), 7.47 (dd, J = 8.4, 1.4
Hz, 1 H), 7.43 (d, J = 8.4
Hz, 1 H).
Methyl 1
H
-Benzo[
d
]imidazole-7-carboxylate
²³
(10)
ESI-MS: m/z = 177.3 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.56
(s, 1 H), 8.31 (s, 1 H), 7.97 (d, J = 8.0
Hz, 1 H), 7.86 (d, J = 7.6
Hz, 1 H), 7.32 (t, J = 7.8
Hz, 1 H), 3.95 (s, 3 H).
1
H
-Benzo[
d
]imidazol-5-ol
²4
(11)
ESI-MS: m/z = 135.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.21
(br s, 1 H), 9.08 (s, 1 H), 8.03 (s, 1 H), 7.37 (d, J = 8.6 Hz,
1 H), 6.87 (s, 1 H), 6.68 (d, J = 8.5
Hz, 1 H).
5-(Allyloxy)-1
H
-benzo[
d
]imidazole
(12)
ESI-MS: m/z = 175.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.25
(s, 1 H), 8.08 (s, 1 H), 7.45 (s, 1 H), 7.08 (s, 1 H), 6.83 (dd, J = 8.7, 2.0
Hz, 1 H), 6.07 (ddt, J = 17.2, 10.5,
5.2 Hz, 1 H), 5.41 (ddd, J = 17.3,
3.4, 1.6 Hz, 1 H), 5.26 (dd, J = 10.5,
1.5 Hz, 1 H), 4.61-4.54 (m, 2 H).
5-(Triisopropylsilyloxy)-1
H
-benzo[
d
]imidazole
(13)
ESI-MS: m/z = 291.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.17
(s, 1 H), 8.09 (s, 1 H), 7.43 (s, 1 H), 6.99 (s, 1 H), 6.76 (d, J = 8.9 Hz,
1 H), 1.25 (dd, J = 14.9,
7.2 Hz, 3 H), 1.07 (d, J = 7.4
Hz, 18 H).
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1
H
-benzo[
d
]imidazole
(14)
ESI-MS: m/z = 245.4 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.48
(s, 1 H), 8.24 (s, 1 H), 7.90 (s, 1 H), 7.57 (s, 1 H), 7.50 (d,
1 H), 1.31 (s, 12 H).
3
H
-Imidazo[4,5-
f
]quinoline
²5
(15)
ESI-MS: m/z = 169.9 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 13.51
(br s, 0.5 H), 12.94 (br s, 0.5 H), 8.86-8.85 (m, 1 H),
8.78 (br s, 1 H), 8.38 (br s, 1 H), 7.97 (br d, J = 7.8
Hz, 1 H), 7.81 (d, J = 8.9
Hz, 1 H), 7.61 (dd, J = 8.3, 4.3
Hz, 1 H).
3-{1
H
-Benzo[
d
]imidazol-5-yl}-3
H
-imidazo[4,5-
b
]pyridine
(16)
ESI-MS: m/z = 250.2 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 12.72
(s, 1 H), 8.83 (s, 1 H), 8.36 (s, 1 H), 8.28 (s, 1 H), 8.13 (s,
1 H), 8.02 (s, 1 H), 7.85-7.60 (m, 2 H), 2.46 (s, 3 H).
6-Bromo-7-methyl-3
H
-imidazo[4,5-
b
]pyridine
²6
(17)
ESI-MS: m/z = 211.9 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 8.42
(s, 1 H), 8.40 (s, 1 H), 2.60 (s, 3 H).
6-Phenyl-1
H
-imidazo[4,5-
c
]pyridine
(18)
ESI-MS: m/z = 196.3 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 9.00
(s, 1 H), 8.40 (s, 1 H), 8.16-8.06 (m, 3 H), 7.53-7.43
(m, 2 H), 7.43-7.34 (m, 1 H).
6-Chloro-1
H
-imidazo[4,5-
c
]pyridine
²7
(19)
ESI-MS: m/z = 153.8 [M + H]+. ¹H
NMR (400 MHz, DMSO): δ = 8.74
(s, 1 H), 8.45 (s, 1 H), 7.67 (s, 1 H).